← board
SNYR
distress 10/10 · high distress / dilution risk$0.18-1%today-95% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.1 yrs
Shares 1y
+58%
Price & events
-90.5% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.1%
1D
-7.2%
1W
-12.6%
1M
-54.8%
3M
-90.3%
6M
-95.1%
1Y
—
2Y
—
5Y
-98.0%
All
Overview
- Market Cap
- $2.70M
- Enterprise Value
- $27.42M
- Volume
- 31.20K
- 52 Week Range
- $0.18 – $3.97
- Total Shares
- 14.90M
- Float Shares
- 8.17M
- Short %
- 1.97%
- % Held by Insiders
- 47.98%
- % Held by Institutions
- 8.61%
- RVOL
- 0.09x
- Beta
- 0.61
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 4
- 2026-08-13Estimated 45%earningsEarningsEarnings releaseyahoo
- 2026-02-27withdrawalFOCUSfactor/Flat Tummy Co. · Termination of Brand License Agreement by Gravity Pharma.SEC 8-K
- 2025-08-18partnershipFOCUSfactor Focus + Energy · Nationwide EG America rollout planned for Q4 2025SEC 8-K
- 2025-06-30partnershipFOCUSfactor · Walmart Canada national launch for FOCUSfactor supplements in Q4 2025.SEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2026-06-10Ascendiant CapitalBuy
- 2026-04-14Ascendiant CapitalBuy
- 2026-02-02Ascendiant CapitalBuy
- 2025-11-14Roth CapitalBuy
- 2025-01-21Roth MKMBuy
Competitors
- none identified
Recent news
- 2026-07-01Synergy CHC (SNYR) slashes 150K executive option strike to $0.21 - Stock Titan
- 2026-07-01Synergy CHC (SNYR) CFO gets 150,000-share option repriced to $0.21 - Stock Titan
- 2026-07-01Synergy CHC (SNYR) CEO-linked entity swaps 750K options at $0.21 - Stock Titan
- 2026-06-25SNYR Forecast — Price Target — Prediction for 2027 - TradingView
- 2026-06-12Synergy CHC Corp. (SNYR) Edges Higher in Low-Price Range as Support Holds - BPI Bull Confirmed - dars.gov.et
- 2026-06-10Synergy CHC Corp. Stock Short Interest Rises to 42.12% - Quiver Quantitative
- 2026-06-07SNYR Q1 2026 Earnings: Massive EPS Miss Triggers Double-Digit Decline - Earnings Forecast Report - dars.gov.et
- 2026-05-30Synergy CHC Corp. (SNYR) Slips 3.3% as Traders Test Support at $0.26 - Hagopian Line - dars.gov.et
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.